Acer Medical Inc. (TPEX:6857)

Market Cap	1.41B -23.3%
Revenue (ttm)	60.05M +19.7%
Net Income	-29.69M
EPS	-1.95
Shares Out	15.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8
Open	92.80
Previous Close	92.80
Day's Range	92.80 - 92.80
52-Week Range	92.00 - 158.50
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Acer Medical

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. The company offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; VeriSee GLC, an AI-assisted screening software for glaucoma suspect; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. It also provides aiMed, a generative AI platform for healthcare environments; aiG...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2018
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6857

Financial Performance

In 2025, Acer Medical's revenue was 60.05 million, an increase of 19.73% compared to the previous year's 50.16 million. Losses were -29.69 million, 8.49% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 21, 2026

Data Sources Report a data error